Enliven Therapeutics, Inc. (ELVN): SCHEDULE 13G/A filed Aug 6, 2026

Form type

SCHEDULE 13G/A

Filing date

Aug 6, 2026

Accession number

0000315066-26-001988

Filer

Enliven Therapeutics, Inc. (CIK 1672619)